Top of this page
Skip navigation, go straight to the content

 

UCB5857

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Lay summary Publication (if available)
APDS
An Open-Label, Exploratory, Multicenter, Extension Study to Evaluate the Long-Term Safety, Tolerability, Pharmacokinetics and Efficacy of UCB5857 in Subjects with Activated Phosphoinositide 3 Kinase (PI3K) Delta Syndrome (APDS) Phase 3 APD003
Terminated
 
2015-005541-30
Sjogren´s Syndrome  A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy of UCB5857 Over 12 Weeks in Subjects With Primary Sjorgen's Syndrome Phase 2 SS0004
Terminated
NCT02610543
2014-004523-51